S&P 500 Futures Fall In Premarket Trading; Intra-Cellular Therapies, Zurn Elkay Water Solns Lead

Dow Jones01-13

This article was automatically generated by Barrons.com using technology from Automated Insights.

With U.S. stock markets set to open in two hours, Intra-Cellular Therapies Inc. (ITCI) was up 35.7% in pre-market trading, and Zurn Elkay Water Solutions Corp. $(ZWS)$ was up 7.4%.

Bank of Montreal $(BMO)$, Humana Inc. $(HUM.UK)$, and Molson Coors Beverage Co. Cl A $(TAP.A)$ were all posting gains of at least 5%. In early trading, Moderna Inc. $(MRNA)$ and IonQ Inc. $(IONQ)$ had posted declines, falling 19.0% and 13.1%, respectively.

Meanwhile S&P 500 futures were down 0.79%, with futures for the Dow Jones Industrial Average falling 0.27%. The Cboe Volatility Index futures were up 7.72%.

In commodities news, Brent crude oil futures were up 1.53%, while gold futures were down 0.85%. Bitcoin was down 4.12% to $90,740.

The 10-Year Treasury yield climbed to 4.780%.

In the previous regular trading session, the S&P 500 and the Dow were down 1.54% and 1.63%, respectively. In Asia overnight, China's Shanghai Composite Index was down 0.25%.

In afternoon trading, stocks in Europe are down, with the STOXX Europe 600 Index falling 0.88% and the FTSE 100 Index declining 0.38% from the previous close.

U.S. stock markets open for trading at 9:30 a.m. ET.

Data source: Dow Jones Market Data, FactSet. Data compiled January 13, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

January 13, 2025 07:30 ET (12:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment